We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Life Sciences Industry Says FDA Needs Reform

Law360 (May 23, 2007, 12:00 AM EDT) -- The U.S. Food and Drug Administration suffers from staffing shortages, drawn out reviews, backlogs of applications and a lack of resources, according to a survey of the top pharmaceutical, biotechnology and life sciences companies.

The industry’s views of the FDA’s drug and medical device approval process emerged in a survey released on Wednesday by PricewaterhouseCoopers LLP and BIOCOM, a life sciences industry association that represents 550 companies in southern California.

“This study is intended to be a working document between the industry and the FDA to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.